Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Alle Spezies anzeigen
Weitere Synonyme anzeigen
Select your species
General TSC2 ELISA Kit für Competition ELISA - ABIN1140792
Feruglio, Trøseid, Damås, Kvale, Dyrhol-Riise: Soluble markers of the Toll-like receptor 4 pathway differentiate between active and latent tuberculosis and are associated with treatment responses. in PLoS ONE 2013
This is the first report using an animal model to show interactions between tsc2, mTORC1 and p53 (zeige TP53 ELISA Kits) during tumorigenesis.
These results demonstrate a highly conserved role of tsc2 in zebrafish and establish a new animal model for studies of Tuberous sclerosis complex.
In our series, consistent with other studies, TSC2 mutations were associated with a more severe phenotypic spectrum than TSC1 (zeige TSC1 ELISA Kits) mutations. This is the first study that sought to characterize the molecular spectrum of Brazilian individuals with tuberous sclerosis
Functional validation of the oncogenic cooperativity and targeting potential of tuberous sclerosis mutation in medulloblastoma using a MYC (zeige MYC ELISA Kits)-amplified model cell line
This case provides evidence for a unique TSC2 mutation that resulted in an atypical clinical presentation and indicates potential shortcomings of the current diagnostic criteria for TSC (zeige SLC12A3 ELISA Kits). These findings may have implications for genetic counseling and screening.
we report a pathogenic TSC2 variant, c.1864C>T, p.(Arg622Trp), associated with a mild phenotype, with most carriers meeting fewer than two major clinical diagnostic criteria for TSC (zeige SLC12A3 ELISA Kits). This finding has significant implications for counseling patients regarding prognosis.
The results highlight a new role of TSC2 in protecting glioblastoma against photodynamic therapy-induced cell death, and TSC2 and YWHAZ (zeige YWHAZ ELISA Kits) as new RIP3 (zeige RIPK3 ELISA Kits) partners.
Study provides new information regarding cerebellar lesions in tuberous sclerosis complex: cerebellar lesions are significantly much more frequent in patients with TSC2 mutations than TSC1 (zeige TSC1 ELISA Kits) mutations or patients with no mutation identified, and Crus II is the most frequent location of cerebellar lesions.
Two pathogenic mutations in TSC1 (zeige TSC1 ELISA Kits) and one in TSC2 genes were identified in patients with tuberous sclerosis complex; the patient with TSC2 mutation manifested a more severe clinical phenotype
Novel missense mutation in the exon 19 of the TSC2 gene is associated with tuberous sclerosis.
our findings suggest the significance of previously undocumented mutation-dependent mTOR (zeige FRAP1 ELISA Kits) hyperactivation and frequent TSC1 (zeige TSC1 ELISA Kits)/2 mutations in HBV-associated HCCs (zeige HCCS ELISA Kits). They define a molecular subset of HCC (zeige FAM126A ELISA Kits) having genetic aberrations in mTOR (zeige FRAP1 ELISA Kits) signalling, with potential significance of effective specific drug therapy.
Mutation in TSC2 is associated with lymphangioleiomyomatosis.
Loss of the tuberous sclerosis complex (TSC (zeige SLC12A3 ELISA Kits)) tumor suppressors results in activation of mTORC1 and development of the tumor syndrome tuberous sclerosis complex (TSC (zeige SLC12A3 ELISA Kits)).
Tsc2-mTOR (zeige FRAP1 ELISA Kits) signaling in mesenchyme is essential for the maintenance of renal structure and for lung alveolarization.
TSC1 (zeige TSC1 ELISA Kits)/TSC2 complex upregulation of OPN (zeige SPP1 ELISA Kits) expression is mediated by transcription factor SOX9 (zeige SOX9 ELISA Kits) in an mTOR (zeige FRAP1 ELISA Kits)-independent manner. Moreover, ablation of OPN (zeige SPP1 ELISA Kits) by deficient TSC1 (zeige TSC1 ELISA Kits)/TSC2 complex contributed to inactivation of AKT (zeige AKT1 ELISA Kits) in TSC (zeige SLC12A3 ELISA Kits) cells
Rheb (zeige RHEB ELISA Kits) and TSC2 have roles in the mechanical activation of mTOR (zeige FRAP1 ELISA Kits) signaling
this study shows that TSC2 maintains macrophage quiescence and prevents mTORC1-dependent granulomatous disease with clinical implications for sarcoidosis
TSC2 N-terminal lysine acetylation status affects to its stability modulating mTORC1 signaling and autophagy/cell proliferation.
Repression of TSC1/TSC2 mediated by MeCP2 regulates human embryo lung fibroblast cell differentiation and proliferation.
Formation of ROS (zeige ROS1 ELISA Kits) and activity of NADPH (zeige FDXR ELISA Kits) oxidases were significantly higher in mouse embryonic fibroblasts and in primary culture of rat renal proximal tubular epithelial tuberin-deficient cells compared to wild-type cells.
Data suggest that pathological cardiac hypertrophy involved class I histone deacetylases HDAC1 (zeige HDAC1 ELISA Kits) and HdAC2 (zeige HDAC2 ELISA Kits), tuberous sclerosis complex 2 (TSC2), and mTOR (zeige FRAP1 ELISA Kits) srine-threonine kinases (mTOR (zeige FRAP1 ELISA Kits)).
autophagy via the TSC2-mTORC1 signaling pathway plays an important role in maintenance of cardiac function and mitochondrial quantity and size in the heart.
Porcine circovirus type 2 (PCV2) might induce autophagy via the AMPK (zeige PRKAA1 ELISA Kits)/ERK (zeige MAPK1 ELISA Kits)/TSC2/mTOR (zeige FRAP1 ELISA Kits) signaling pathway in the host cells, representing a pivotal mechanism for PCV2 pathogenesis
prostaglandin F2alpha phosphorylates TSC2 and activates mTOR (zeige FRAP1 ELISA Kits) and ribosomal protein S6 (zeige RPS6 ELISA Kits) kinase (zeige RPS6KB1 ELISA Kits) signaling in an AKT (zeige AKT1 ELISA Kits)-independent manner
Mutations in this gene lead to tuberous sclerosis complex. Its gene product is believed to be a tumor suppressor and is able to stimulate specific GTPases. The protein associates with hamartin in a cytosolic complex, possibly acting as a chaperone for hamartin. Alternative splicing results in multiple transcript variants encoding different isoforms.
tuberous sclerosis complex 2 (TSC2)
, tuberous sclerosis 2
, tuberous sclerosis 2 protein
, tuberous sclerosis 2 protein homolog
, renal carcinoma
, tuberous sclerosis 2 homolog protein